REGENERON PHARMACEUTICALS, INC. Income Tax Expense 2008-2026 | REGN
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is REGENERON PHARMACEUTICALS, INC.'s current income tax expense?
REGENERON PHARMACEUTICALS, INC. (REGN) annual income tax expense for 2025 was $725.8M, a 97.60% increase from 2024. REGENERON PHARMACEUTICALS, INC. income tax expense for the quarter ending March 31, 2026 was $104.0M.
What was REGENERON PHARMACEUTICALS, INC.'s income tax expense in 2024?
REGENERON PHARMACEUTICALS, INC. annual income tax expense for 2024 was $367.3M, a 49.49% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s income tax expense in 2023?
REGENERON PHARMACEUTICALS, INC. annual income tax expense for 2023 was $245.7M, a 52.79% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year income tax expense CAGR?
REGENERON PHARMACEUTICALS, INC. income tax expense grew at a compound annual growth rate (CAGR) of 19.55% from FY2020 to FY2025, going from $297.2M to $725.8M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $725.8M | +97.6% | 10-K |
| FY2024 | $367.3M | +49.5% | 10-K |
| FY2023 | $245.7M | -52.8% | 10-K |
| FY2022 | $520.4M | -58.4% | 10-K |
| FY2021 | $1.25B | +320.8% | 10-K |
| FY2020 | $297.2M | -5.1% | 10-K |
| FY2019 | $313.3M | +187.2% | 10-K |
| FY2018 | $109.1M | -87.6% | 10-K |
| FY2017 | $880.0M | +102.6% | 10-K |
| FY2016 | $434.3M | -26.3% | 10-K |
| FY2015 | $589.0M | +39.2% | 10-K |
| FY2014 | $423.1M | +49.7% | 10-K |
| FY2013 | $282.6M | +184.2% | 10-K |
| FY2012 | $-335.8M | -29568.6% | 10-K |
| FY2011 | $-1.1M | - | 10-K |
| FY2010 | $0 | +100.0% | 10-K |
| FY2009 | $-4.1M | -275.3% | 10-K |
| FY2008 | $2.4M | - | 10-K |